Merrill Lynch and JP Morgan led the initial public offering (IPO) of Kinectic Concepts, the largest US biotech flotation this year, which saw shares rise 29% on the morning of its first day's trading.

The IPO of the medical technology firm raised $540m (€429m) and continues the strong performance posted by US biotech IPOs this year.